Clinical Trial Update: An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating onset of action of fluticasone furoate nasal spray and olopatadine nasal spray versus placebo for allergic rhinitis has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Fluticasone furoate nasal spray (fluticasone furoate)
• Olopatadine nasal spray (olopatadine)

Snippet

Sponsor: ORA, Inc. | Conditions: Allergic Rhinitis | Phase 4 | Status: WITHDRAWN